Trial intelligence / Profile preview

Typhoid Conjugate Vaccine Booster in Burkina Faso Children

NCT07624175Phase 2Completed

Start
Aug 2024
Primary completion
Oct 2024
Countries
1
01

Overview

A Phase 2 trial of TyphiBEV in typhoid fever. Started Aug 2024; status: completed.

02

Drugs

TyphiBEV
03

Conditions

typhoid fever

Beyond the preview

Go deeper on NCT07624175.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07624175.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call